Find Reports
Select Report Type
Reimbursement Review
Displaying 751 - 775 of 1426
Please scroll or swipe to the right to view the full content.
| Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|---|
| Tocilizumab | Actemra | Tocilizumab | Arthritis, rheumatoid | List with criteria/condition | Complete | SR0374-000 | |||
| Arzerra for Chronic Lymphocyti... | Arzerra | Ofatumumab | Chronic Lymphocytic Leukemia | Do not reimburse | Complete | PC0038-000 | |||
| Macitentan | Opsumit | Macitentan | Pulmonary arterial hypertension | List with clinical criteria and/or conditions | Complete | SR0364-000 | |||
| Gazyva for Chronic Lymphocytic... | Gazyva | Obinutuzumab | Chronic Lymphocytic Leukemia | Reimburse | Complete | PC0041-000 | |||
| Alogliptin | Nesina | Alogliptin | Diabetes mellitus, type 2 | Do not list | Complete | SR0368-000 | |||
| Alogliptin Plus Metformin | Kazano | Alogliptin plus metformin | Diabetes mellitus, type 2 | Do not list | Complete | SR0367-000 | |||
| Canagliflozin | Invokana | Canagliflozin | Diabetes mellitus, type 2 | List with criteria/condition | Complete | SR0370-000 | |||
| Umeclidinium/vilanterol | Anoro Ellipta | Umeclidinium/vilanterol | Chronic obstructive pulmonary disease | List with criteria/condition | Complete | SR0371-000 | |||
| Yervoy for First Line Advanced... | Yervoy | Ipilimumab | First Line Advanced Melanoma | Reimburse with clinical criteria and/or conditions | Complete | PC0042-000 | |||
| Aripiprazole | Abilify Maintena | Aripiprazole | Schizophrenia | List with criteria/condition | Complete | SR0366-000 | |||
| Indacaterol/glycopyrronium | Ultibro Breezhaler | Indacaterol/glycopyrronium | Chronic obstructive pulmonary disease | List with criteria/condition | Complete | SR0369-000 | |||
| Icatibant | Firazyr | Icatibant | Hereditary angioedema | List with clinical criteria and/or conditions | Complete | SR0375-000 | |||
| Ivacaftor | Kalydeco | Ivacaftor | Cystic Fibrosis, CFTR gating mutations | List with criteria/condition | Complete | SR0379-000 | |||
| Infliximab | Inflectra | Infliximab | Ankylosing spondylitis; arthritis, psoriatic; arthritis, rheumatoid; plaque psoriasis | List with criteria/condition | Complete | SE0384-000 | |||
| OnabotulinumtoxinA | Botox | OnabotulinumtoxinA | Urinary incontinence | List with criteria/condition | Complete | SR0362-000 | |||
| Mirabegron | Myrbetriq | Mirabegron | Overactive bladder | List with criteria/condition | Complete | SR0363-000 | |||
| Aripiprazole | Abilify | Aripiprazole | Depression, Major Depressive Disorder | Do not list | Complete | SR0354-000 | |||
| Ustekinumab | Stelara | Ustekinumab | Arthritis, psoriatic | Do not list at the submitted price | Complete | SR0359-000 | |||
| Aflibercept | Eylea | Aflibercept | Macular degeneration, age-related | List with criteria/condition | Complete | SR0361-000 | |||
| Stiripentol | Diacomit | Stiripentol | Dravet Syndrome | List with criteria/condition | Complete | SR0360-000 | |||
| Guanfacine hydrochloride | Intuniv XR | Guanfacine hydrochloride | Attention-deficit/hyperactivity disorder (ADHD) | Do not list | Complete | SR0349-000 | |||
| Phleum pratense | Grastek | Phleum pratense | Allergic rhinitis | Do not list | Complete | SR0352-000 | |||
| Abraxane for Metastatic Pancre... | Abraxane | Nab-paclitaxel | Metastatic Pancreatic Cancer | Reimburse with clinical criteria and/or conditions | Complete | PC0037-000 | |||
| Zaltrap for Metastatic Colorec... | Zaltrap | Aflibercept | Metastatic Colorectal Cancer | Do not reimburse | Complete | PC0035-000 | |||
| Dolutegravir | Tivicay | Dolutegravir | HIV infection | List | Complete | SR0357-000 |
Health Technology Review
Displaying 601 - 602 of 602
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 751 - 775 of 2138
Please scroll or swipe to the right to view the full content.
| Title | Description | Files | Last Updated Sort ascending | Project Line | Project Sub Line | Status | Project Number |
|---|---|---|---|---|---|---|---|
| Treatment Options for VEXAS Syndrome | Health Technology Review | Rapid Review | Completed | RC1460-000 | |||
| CADTH Pharmaceutical Reviews Update — Issue 32 | Reimbursement Review | Pharmaceutical Review Update | |||||
| Intravenous Iron Preparations for Patients Undergoing Elective Surgery: A 2022 Update | Health Technology Review | Rapid Review | Completed | RC1457-000 | |||
| Peer Support Programs for Youth Mental Health | Health Technology Review | Health Technology Assessment | Completed | HT0036-000 | |||
| nusinersen | Reimbursement Review | Complete | SR0713-000 | ||||
| Raltitrexed in patients with dihydropyrimidine dehydrogenase (DPD) deficiency | Health Technology Review | Reference List | Completed | RC1463-000 | |||
| Transanal Total Mesorectal Excision for Adult Patients with Rectal Cancer | Health Technology Review | Rapid Review | Completed | RC1459-000 | |||
| mogamulizumab | Reimbursement Review | Complete | PC0244-000 | ||||
| abaloparatide | Reimbursement Review | Withdrawn | SR0744-000 | ||||
| Robotic Surgical Systems for Orthopedics | Horizon Scan | Emerging Health Technologies | Completed | EH0108-000 | |||
| Rapid Syphilis Testing | Horizon Scan | Health Technology Update | Completed | EN0043-000 | |||
| Liposuction for Lymphedema | Health Technology Review | Rapid Review | Completed | RC1458-000 | |||
| Oral Feeding for Preterm Infants on Respiratory Support | Health Technology Review | Rapid Review | Completed | RC1461-000 | |||
| Rural Healthcare Planning Initiatives and Frameworks | Health Technology Review | Health Technology Assessment | Completed | HC0044-000 | |||
| Intravenous Iron Isomaltoside for Patients with Iron Deficiency Undergoing Elective Surgery | Health Technology Review | Rapid Review | Completed | RC1456-000 | |||
| Pediatric Glioma Learning Project | Health Technology Review | Technology Review | Active | HM0001-000 | |||
| Evusheld for the Treatment of Mild to Moderate COVID-19 | Health Technology Review | Technology Review | Completed | HC0041-000 | |||
| Azacitidine for Acute myeloid leukemia | Health Technology Review | Technology Review | Completed | HC0036-000 | |||
| Real-Time Continuous Glucose Monitoring: A Review of Guidelines | Health Technology Review | Summary with Critical Appraisal | Completed | RC1449-000 | |||
| sodium phenylbutyrate and ursodoxicoltaurine | Reimbursement Review | Complete | SR0711-000 | ||||
| ruxolitinib | Reimbursement Review | Complete | SR0706-000 | ||||
| upadacitinib | Reimbursement Review | Complete | SR0685-000 | ||||
| selinexor | Reimbursement Review | Complete | PC0276-000 | ||||
| Treatment Strategies for Sexual Dysfunction Associated With Psychotropic Medications | Health Technology Review | Rapid Review | Completed | RC1455-000 | |||
| lenvatinib and pembrolizumab | Reimbursement Review | Complete | PC0268-000 |
Provisional Funding Algorithm
Displaying 76 - 81 of 81